Rankings
▼
Calendar
BSX Q2 2017 Earnings — Boston Scientific Corporation Revenue & Financial Results | Market Cap Arena
BSX
Boston Scientific Corporation
$103B
Q2 2017 Earnings
Healthcare
Medical - Devices
Income Statement
Revenue
$2.3B
+6.2% YoY
Gross Profit
$1.5B
65.0% margin
Operating Income
$395M
17.5% margin
Net Income
$146M
6.5% margin
EPS (Diluted)
$0.10
QoQ Revenue Growth
+4.5%
Cash Flow
Operating Cash Flow
$297M
Free Cash Flow
$210M
Stock-Based Comp.
$32M
Balance Sheet
Total Assets
$18.4B
Total Liabilities
$11.1B
Stockholders' Equity
$7.2B
Cash & Equivalents
$195M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$2.3B
$2.1B
+6.2%
Gross Profit
$1.5B
$1.5B
+0.1%
Operating Income
$395M
-$334M
+218.3%
Net Income
$146M
-$207M
+170.5%
Revenue Segments
Cardiovascular
$889M
51%
MedSurg
$841M
49%
← FY 2017
All Quarters
Q3 2017 →